Literature DB >> 8177396

Reduction of vasogenic edema and infarction by MK-801 in rats after temporary focal cerebral ischemia.

G Yang1, P H Chan, S F Chen, O A Babuna, R P Simon, P R Weinstein.   

Abstract

Blood-brain barrier permeability alteration, vasogenic brain edema, and infarction, which are more extensive after 3 hours of temporary middle cerebral artery occlusion (MCAO) and 3 hours of reperfusion than after 6 hours of permanent MCAO, develop in rats after prolonged focal cerebral ischemia. Protective effects of excitatory amino acid receptor antagonists have been previously demonstrated after temporary global ischemia and permanent focal ischemia in rats. The purpose of this study was to evaluate the effectiveness of MK-801, a noncompetitive N-methyl-D-aspartate receptor antagonist, in temporary middle cerebral artery occlusion in rats maintained at physiological levels of brain temperature. Rats were anesthetized with chloral hydrate (350 mg/kg, intraperitoneally). The MCAO of rats was occluded by cannulation with a nylon suture for 3 hours, followed by 3 hours of reperfusion accomplished by withdrawing the suture. MK-801 (1 mg/kg, intravenously) or saline (S) was injected immediately before the onset of MCAO. Water content (MK-801, n = 6; S, n = 6), Evans blue dye extravasation (MK-801, n = 6; S, n = 6), infarct volume (MK-801, n = 10; S, n = 10), histology (MK-801, n = 6; S, n = 6), and neurological deficit (MK-801, n = 15; S, n = 18) were measured at the end of 3 hours of reperfusion. Brain temperature was monitored during the experiment. The infarction area (measured by 2, 3, 5-triphenyltetrazolium chloride staining) was reduced (P < 0.001) in the MK-801-treated rats, as was the infarct volume and the severity of neuronal damage (P < 0.01).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8177396     DOI: 10.1227/00006123-199402000-00018

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  7 in total

1.  Dose-related influence of chronic alcohol consumption on cerebral ischemia/reperfusion injury.

Authors:  Honggang Zhao; William G Mayhan; Denise M Arrick; Wanfen Xiong; Hong Sun
Journal:  Alcohol Clin Exp Res       Date:  2011-02-25       Impact factor: 3.455

2.  Peroxisome proliferator-activated receptor-γ (PPAR-γ) activation confers functional neuroprotection in global ischemia.

Authors:  Zahra Fatehi-Hassanabad; R A Tasker
Journal:  Neurotox Res       Date:  2010-06-04       Impact factor: 3.911

3.  Effects of blockade of ionotropic glutamate receptors on blood-brain barrier disruption in focal cerebral ischemia.

Authors:  Xia Liu; Christine Hunter; Harvey R Weiss; Oak Z Chi
Journal:  Neurol Sci       Date:  2010-03-09       Impact factor: 3.307

4.  Neuroprotection by neuregulin-1 in a rat model of permanent focal cerebral ischemia.

Authors:  Yonggang Li; Zhenfeng Xu; Gregory D Ford; Dajoie R Croslan; Tariq Cairobe; Zhenzhong Li; Byron D Ford
Journal:  Brain Res       Date:  2007-09-22       Impact factor: 3.252

5.  Effects of exogenous excitatory amino acid neurotransmitters on blood-brain barrier disruption in focal cerebral ischemia.

Authors:  Oak Z Chi; Christine Hunter; Xia Liu; Harvey R Weiss
Journal:  Neurochem Res       Date:  2009-01-06       Impact factor: 3.996

Review 6.  Biomaterials to Neuroprotect the Stroke Brain: A Large Opportunity for Narrow Time Windows.

Authors:  Daniel González-Nieto; Rocío Fernández-Serra; José Pérez-Rigueiro; Fivos Panetsos; Ricardo Martinez-Murillo; Gustavo V Guinea
Journal:  Cells       Date:  2020-04-26       Impact factor: 6.600

7.  Pharmacological Effect of Panax notoginseng Saponins on Cerebral Ischemia in Animal Models.

Authors:  Chao Dong; Jiawei Li; Ming Zhao; Lin Chen; Xiaochen Zhai; Lingling Song; Jin Zhao; Qiang Sun; Jie Wu; Xiaolu Xie
Journal:  Biomed Res Int       Date:  2022-08-04       Impact factor: 3.246

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.